Printer Friendly

NSAID, proton pump combo.

Prevacid NapraPAC (lansoprazole delayed-release capsules and naproxen tablets kit) is now approved for reduction of NSAID-associated gastric ulcers in patients with a history of a documented gastric ulcer who require the use of an NSAID for the treatment of the signs and symptoms of rheumatoid arthritis, osteoarthritis and ankylosing spondylitis. The blister packs come in 15-mg lansoprazole/250-mg naproxen, 15-mg/375-mg, and 15-mg/500-mg doses. For more information, contact Tap Pharmaceutical Products Inc., call 800-622-2011, or on the web at www.prevacid.com/naprapac/pi.
COPYRIGHT 2004 International Medical News Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Products
Publication:OB GYN News
Date:Jan 1, 2004
Words:85
Previous Article:Weather does aggravate joint symptoms: folklore confirmed.
Next Article:Panel backs OTC switch for Plan B: emergency contraception.
Topics:


Related Articles
Regular NSAID use may block heart benefits of aspirin: study of American male doctors.
Acid blockers stop stomach ulcers, too.
Uncertain about COX-2s? Consider NSAID + PPI.
PPI cotherapy strategy gets a second look.
H. pylori eradication does not prevent NSAID-related ulcers.
PPIs prescribed along with NSAIDs almost 50% of time.
Anti-inflammatories, arthritis and gastric outcomes.
Reducing gastrointestinal risks of NSAID therapy.
PPIs to prevent NSAID-induced GI ulceration.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters